why choose us

First received: June 03, 2023

Clinical Trial: The Efficacy and Safety of Corticosteroids in Combination With Ruxolitinib in the Management of Checkpoint Inhibitor Pneumonia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Severe Checkpoint Inhibitor Pneumonitis

Study Type: INTERVENTIONAL


Official Title: The Efficacy and Safety of Corticosteroids in Combination With Biological Agents in the Management of Severe Immune Related Adverse Events Cohort A: The Efficacy and Safety of Corticosteroids or Corti

Brief Summary: This study is a prospective multicenter randomized controlled Interventional study, to assess the clinical efficacy and safety of corticosteroids compared to corticosteroids in combination with Ruxolitinib in the treatment of severe checkpoint inhibitor pneumonitis.

Read more